AKT inhibitor VIII
CAS No. 612847-09-3
AKT inhibitor VIII ( AKT inhibitor VIII; AKT-inhibitor-VIII; AKT inhibitor-8; AKT-inhibitor-8; Akt-I 1,2; Akti-1/2. Sigma-A6730 )
Catalog No. M15308 CAS No. 612847-09-3
A selective, allosteric Akt inhibitor with IC50 of 58/210 for Akt1/2 respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 55 | In Stock |
|
5MG | 96 | In Stock |
|
10MG | 140 | In Stock |
|
25MG | 250 | In Stock |
|
50MG | 410 | In Stock |
|
100MG | 605 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAKT inhibitor VIII
-
NoteResearch use only, not for human use.
-
Brief DescriptionA selective, allosteric Akt inhibitor with IC50 of 58/210 for Akt1/2 respectively.
-
DescriptionA selective, allosteric Akt inhibitor with IC50 of 58/210 for Akt1/2 respectively; shows weak activity for Akt3 (IC50=2.12 uM); inhibits basal and IGF stimulated Akt1 and Akt2 phosphorylation in mouse lung, with no effect on Akt3 phosphorylation.
-
SynonymsAKT inhibitor VIII; AKT-inhibitor-VIII; AKT inhibitor-8; AKT-inhibitor-8; Akt-I 1,2; Akti-1/2. Sigma-A6730
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorAkt1;Akt2;Akt3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number612847-09-3
-
Formula Weight551.64
-
Molecular FormulaC34H29N7O
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C1N(C2CCN(CC3=CC=C(C4=NC5=CC6=C(N=CN6)C=C5N=C4C7=CC=CC=C7)C=C3)CC2)C8=CC=CC=C8N1
-
Chemical Name2H-Benzimidazol-2-one, 1,3-dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]-4-piperidinyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lindsley, et al. Bioorg. Med. Chem. Lett. (2005), 15(3), 761-764.
2. Romorini L, et al. Sci Rep. 2016 Oct 20;6:35660.
2. Romorini L, et al. Sci Rep. 2016 Oct 20;6:35660.
molnova catalog
related products
-
Afuresertib
A potent, selective, ATP-competitive pan-AKT inhibitor with biochemical IC50 of 0.08/2/2.6 nM for AKT1/2/3.
-
Pachymic acid
Pachymic acid is a natural product, and inhibits Akt and ERK signaling pathways.Pachymic acid(PA) exhibited anti-tumor effects in vitro accompanied by induction of G2/M phase arrest and apoptosis in NCI-H23 and NCI-H460 lung cancer cells.?
-
Demethyleneberberine
Demethyleneberberine, which is composed of a potential antioxidant structure, could penetrate the membrane of mitochondria and accumulate in mitochondria either in vitro or in vivo.